BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Tan H, Yu T, Chen X, Jing F, Shi H. Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines. Front Immunol 2021;12:755401. [DOI: 10.3389/fimmu.2021.755401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng L, Yang K, Kuang Q, Peng M, Li L, Luo P, Acharya B. A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/8408328] [Reference Citation Analysis]
2 Feng L, Yang J, Zhang W, Wang X, Li L, Peng M, Luo P. Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. Front Oncol 2022;12:994703. [DOI: 10.3389/fonc.2022.994703] [Reference Citation Analysis]
3 Huang Q, Yang S, Yan H, Chen H, Wang Y, Wang Y. Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma. Front Genet 2022;13:907058. [DOI: 10.3389/fgene.2022.907058] [Reference Citation Analysis]
4 Gu X, Wei S, Li Z, Xu H. Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma. Front Immunol 2022;13:1022149. [DOI: 10.3389/fimmu.2022.1022149] [Reference Citation Analysis]
5 Li G, Luo Q, Wang X, Zeng F, Feng G, Che G. Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma. Front Endocrinol 2022;13:970269. [DOI: 10.3389/fendo.2022.970269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peng B, Lou H, Chen C, Wang L, Li H, Lu T, Na R, Xu R, Xin T, Yao L, Xu H, Wang K, Liu X, Zhang L. Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma. Front Genet 2022;13:870302. [DOI: 10.3389/fgene.2022.870302] [Reference Citation Analysis]